Dr. Castillo leads the strategic direction, capability development and execution of the research and development activities of CNL’s Hydrogen and Tritium Directorate. This includes understanding various stakeholder needs with the government, assessing market trends and establishing a technology portfolio to leverage CNL’s decades of hydrogen isotopes experience, and uses for CNL’s unique differentiating facilities and capabilities.

With over 17 years in many areas of the nuclear industry, Ian is recognized as an expert. Dr. Castillo is providing the strategic direction for upcoming Canada’s Fusion Roadmap for the Government of Canada and is also the General Conference Chair of the upcoming 14th Tritium Science International Conference in Ottawa in 2025.